Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Smith

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|November 2, 2020
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acidsMichael A Glaysher, James Ward, Madhawi Aldhwayan, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Elife|January 10, 2019
Comparisons between the ON- and OFF-edge motion pathways in the <i>Drosophila</i> brainKazunori Shinomiya, Gary Huang, Zhiyuan Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory CancerSeung Tae Kim, Simon A Smith, Peter Mortimer, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
BMJ Open|November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitusMichael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
Maternal & Child Nutrition|September 2, 2024
Household food insecurity and novel complementary feeding methods in New Zealand familiesIoanna Katiforis, Claire Smith, Jillian J Haszard, et al.
Public Health Nutrition|November 3, 2025
Household food insecurity, nutrient intakes and BMI in New Zealand infantsIoanna Katiforis, Claire Smith, Jillian J Haszard, et al.
BMC Research Notes|October 13, 2018
Sepsis-related deaths in the at-risk population on the wards: attributable fraction of mortality in a large point-prevalence studyMaja Kopczynska, Ben Sharif, Sian Cleaver, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2019
Correction: Biallelic sequence and structural variants in RAX2 are a novel cause for autosomal recessive inherited retinal diseaseStijn Van de Sompele, Claire Smith, Marianthi Karali, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Clinical Nutrition (Edinburgh, Scotland)|November 2, 2020
The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acidsMichael A Glaysher, James Ward, Madhawi Aldhwayan, et al.
Neuro-Oncology|February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastomaAlba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Elife|January 10, 2019
Comparisons between the ON- and OFF-edge motion pathways in the <i>Drosophila</i> brainKazunori Shinomiya, Gary Huang, Zhiyuan Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory CancerSeung Tae Kim, Simon A Smith, Peter Mortimer, et al.
International Journal of Molecular Sciences|May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineDavid Capper, Andreas von Deimling, Alba A Brandes, et al.
BMJ Open|November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitusMichael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
Maternal & Child Nutrition|September 2, 2024
Household food insecurity and novel complementary feeding methods in New Zealand familiesIoanna Katiforis, Claire Smith, Jillian J Haszard, et al.
Public Health Nutrition|November 3, 2025
Household food insecurity, nutrient intakes and BMI in New Zealand infantsIoanna Katiforis, Claire Smith, Jillian J Haszard, et al.
BMC Research Notes|October 13, 2018
Sepsis-related deaths in the at-risk population on the wards: attributable fraction of mortality in a large point-prevalence studyMaja Kopczynska, Ben Sharif, Sian Cleaver, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 5, 2019
Correction: Biallelic sequence and structural variants in RAX2 are a novel cause for autosomal recessive inherited retinal diseaseStijn Van de Sompele, Claire Smith, Marianthi Karali, et al.
Pageof 17